We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOW
2651
DELISTED
WideOpenWest
WOW
$255K ﹤0.01%
41,415
+2,363
+6% +$15.4K
BGSF icon
2652
BGSF Inc
BGSF
$60.4M
$254K ﹤0.01%
13,298
+720
+6% +$13.4K
RLGT icon
2653
Radiant Logistics
RLGT
$392M
$254K ﹤0.01%
49,047
-400
-0.8% -$2.08K
SGRY icon
2654
Surgery Partners
SGRY
$2B
$254K ﹤0.01%
34,402
+2,763
+9% +$19.8K
APYX icon
2655
Apyx Medical
APYX
$174M
$253K ﹤0.01%
37,346
+6,634
+22% +$47.1K
BE icon
2656
Bloom Energy
BE
$69B
$253K ﹤0.01%
77,697
+7,439
+11% +$55.6K
INO icon
2657
Inovio Pharmaceuticals
INO
$70M
$253K ﹤0.01%
10,279
-75
-0.7% -$2.28K
TPTX
2658
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$253K ﹤0.01%
6,729
+911
+16% +$39.7K
ESSA
2659
DELISTED
ESSA Bancorp
ESSA
$252K ﹤0.01%
15,337
+1,233
+9% +$18.9K
BFIN
2660
DELISTED
BankFinancial
BFIN
$251K ﹤0.01%
21,116
+2,094
+11% +$26.3K
GPX
2661
DELISTED
GP Strategies Corp.
GPX
$251K ﹤0.01%
19,555
+1,871
+11% +$26.4K
VRCA icon
2662
Verrica Pharmaceuticals
VRCA
$94.7M
$250K ﹤0.01%
1,692
+90
+6% +$10K
WLFC icon
2663
Willis Lease Finance
WLFC
$1.56B
$250K ﹤0.01%
13,554
+1,104
+9% +$22.3K
BRT
2664
BRT Apartments
BRT
$267M
$247K ﹤0.01%
16,959
+1,407
+9% +$19.7K
BSET icon
2665
Bassett Furniture
BSET
$170M
$247K ﹤0.01%
16,133
+1,265
+9% +$16.7K
SLDB icon
2666
Solid Biosciences
SLDB
$859M
$247K ﹤0.01%
1,589
+272
+21% +$30.8K
CURO
2667
DELISTED
CURO Group Holdings Corp.
CURO
$247K ﹤0.01%
18,590
-175
-0.9% -$2.23K
VRAY
2668
DELISTED
ViewRay, Inc.
VRAY
$247K ﹤0.01%
85,241
-2,185
-2% -$12.9K
RVSB icon
2669
Riverview Bancorp
RVSB
$109M
$246K ﹤0.01%
33,391
+2,700
+9% +$21K
FNWB icon
2670
First Northwest Bancorp
FNWB
$106M
$245K ﹤0.01%
14,153
+959
+7% +$15.6K
NBN icon
2671
Northeast Bank
NBN
$1.14B
$245K ﹤0.01%
11,036
+878
+9% +$18.7K
USLM icon
2672
United States Lime & Minerals
USLM
$3.38B
$245K ﹤0.01%
16,015
+1,205
+8% +$19.4K
CBMG
2673
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$245K ﹤0.01%
16,459
-595
-3% -$8.02K
SGC icon
2674
Superior Group of Companies
SGC
$216M
$244K ﹤0.01%
15,157
+968
+7% +$15.1K
MLVF
2675
DELISTED
Malvern Bancorp, Inc.
MLVF
$244K ﹤0.01%
11,186
+800
+8% +$17.2K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.